The effects of engineered nanoparticles on pulmonary immune homeostasis

References

• Akbarzadeh A, Samiei M, Davaran S. (2012). Magnetic nanoparticles: Preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett 7:144--156
   PubMed Web of Science ®Google Scholar
• Alves Cardoso D, Jansen JA, Leeuwenburgh SC. (2012). Synthesis and application of nanostructured calcium phosphate ceramics for bone regeneration. J Biomed Mater Res B Appl Biomater 100:2316–2326
   PubMed Web of Science ®Google Scholar
• Ambalavanan N, Stanishevsky A, Bulger A, et al. (2013). Titanium oxide nanoparticle instillation induces inflammation and inhibits lung development in mice. Am J Physiol Lung Cell Mol Physiol 304:L152–L161
   PubMed Web of Science ®Google Scholar
• Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. (2010). Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 62:59–82
   PubMed Web of Science ®Google Scholar
• Andrade F, Videira M, Ferreira D, Sarmento B. (2011). Nanocarriers for pulmonary administration of peptides and therapeutic proteins. Nanomedicine (Lond) 6:123–141
   PubMed Web of Science ®Google Scholar
• Asharani PV, Hande MP, Valiyaveettil S. (2009a). Anti-proliferative activity of silver nanoparticles. BMC Cell Biol 10:65
   PubMed Web of Science ®Google Scholar
• AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. (2009b). Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279–290
   PubMed Web of Science ®Google Scholar
• Baker GL, Gupta A, Clark ML, et al. (2008). Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles. Toxicol Sci 101:122–131
   PubMed Web of Science ®Google Scholar
• Banerjee S, Kahn MG, Wong SS. (2003). Rational chemical strategies for carbon nanotube functionalization. Chemistry 9:1898–1908
   PubMed Web of Science ®Google Scholar
• Barceloux DG. (1999). Zinc. J Toxicol Clin Toxicol 37:279–292
   PubMed Web of Science ®Google Scholar
• Barik TK, Sahu B, Swain V. (2008). Nanosilica-from medicine to pest control. Parasitol Res 103:253–258
   PubMed Web of Science ®Google Scholar
• Bernard BK, Osheroff MR, Hofmann A, Mennear JH. (1990). Toxicology and carcinogenesis studies of dietary titanium dioxide-coated mica in male and female Fischer 344 rats. J Toxicol Environ Health 29:417–429
   PubMed Web of Science ®Google Scholar
• Bhol KC, Schechter PJ. (2007). Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Dig Dis Sci 52:2732–2742
   PubMed Web of Science ®Google Scholar
• Blank F, Stumbles PA, Seydoux E, et al. (2013). Size-dependent uptake of particles by pulmonary APC populations and trafficking to regional lymph nodes. Am J Respir Cell Mol Biol 49:66--77
   Google Scholar
• Bonner JC. (2011). Carbon nanotubes as delivery systems for respiratory disease: Do the dangers outweigh the potential benefits? Expert Rev Respir Med 5:779–787
   PubMed Web of Science ®Google Scholar
• Brown SD, Nativo P, Smith JA, et al. (2010). Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 132:4678–4684
   PubMed Web of Science ®Google Scholar
• Brunner TJ, Wick P, Manser P, et al. (2006). In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 40:4374–4381
   PubMed Web of Science ®Google Scholar
• Bur M, Henning A, Hein S, et al. (2009). Inhalative nanomedicine – Opportunities and challenges. Inhal Toxicol 21:137–143
   PubMedGoogle Scholar
• Card JW, Zeldin DC, Bonner JC, Nestmann ER. (2008). Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 295:L400–L411
   PubMed Web of Science ®Google Scholar
• Chang H, Ho CC, Yang CS, et al. (2013). Involvement of MyD88 in zinc oxide nanoparticle-induced lung inflammation. Exp Toxicol Pathol 65:887–896
   PubMed Web of Science ®Google Scholar
• Chen X, Schluesener HJ. (2008). Nanosilver: A nanoproduct in medical application. Toxicol Lett 176:1–12
   PubMed Web of Science ®Google Scholar
• Chen YS, Hung YC, Liau I, Huang GS. (2009). Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett 4:858–864
   PubMed Web of Science ®Google Scholar
• Chittasupho C, Xie SX, Baoum A, et al. (2009). ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur J Pharm Sci 37:141–150
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Kim SR, et al. (2009). Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging. Toxicol Appl Pharmacol 239:106–115
   PubMed Web of Science ®Google Scholar
• Cho WS, Choi M, Han BS, et al. (2007a). Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol Lett 175:24–33
   PubMed Web of Science ®Google Scholar
• Cho WS, Duffin R, Poland CA, et al. (2012). Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 6:22–35
   PubMed Web of Science ®Google Scholar
• Cho YW, Park SA, Han TH, et al. (2007b). In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: Mechanisms, key factors, and their implications. Biomaterials 28:1236–1247
   PubMed Web of Science ®Google Scholar
• Choi M, Cho M, Han BS, et al. (2010). Chitosan nanoparticles show rapid extrapulmonary tissue distribution and excretion with mild pulmonary inflammation to mice. Toxicol Lett 199:144–152
   PubMed Web of Science ®Google Scholar
• Coccini T, Roda E, Barni S, et al. (2012). Long-lasting oxidative pulmonary insult in rat after intratracheal instillation of silica nanoparticles doped with cadmium. Toxicology 302:203–211
   PubMed Web of Science ®Google Scholar
• Condon TV, Sawyer RT, Fenton MJ, Riches DW. (2011). Lung dendritic cells at the innate-adaptive immune interface. J Leukoc Biol 90:883–895
   PubMed Web of Science ®Google Scholar
• Connor EE, Mwamuka J, Gole A, et al. (2005). Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325–327
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm PJ. (2008). Drug delivery and nanoparticles: Applications and hazards. Int J Nanomedicine 3:133–149
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, et al. (2008). Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912--1919
   Google Scholar
• Derakhshandeh K, Fathi, S. (2012). Role of chitosan nanoparticles in the oral absorption of Gemcitabine. Int J Pharm 437:172–177
   PubMed Web of Science ®Google Scholar
• Dhand, R. (2004). New frontiers in aerosol delivery during mechanical ventilation. Respir Care 49:666–677
   PubMedGoogle Scholar
• Ding N, Kunugita N, Ichinose T, et al. (2011). Intratracheal administration of fullerene nanoparticles activates splenic CD11b+ cells. J Hazard Mater 194:324–330
   PubMed Web of Science ®Google Scholar
• Dorney J, Bonnier F, Garcia A, et al. (2012). Identifying and localizing intracellular nanoparticles using Raman spectroscopy. Analyst 137:1111–1119
   PubMed Web of Science ®Google Scholar
• dos Santos T, Varela J, Lynch I, et al. (2011). Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 6:e24438
   PubMed Web of Science ®Google Scholar
• Dostert C, Petrilli V, Van Bruggen R, et al. (2008). Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677
   PubMed Web of Science ®Google Scholar
• Downs TR, Crosby ME, Hu T, et al. (2012). Silica nanoparticles administered at the maximum tolerated dose induce genotoxic effects through an inflammatory reaction while gold nanoparticles do not. Mutat Res 745:38–50
   PubMed Web of Science ®Google Scholar
• Edwards DA, Dunbar C. (2002). Bioengineering of therapeutic aerosols. Annu Rev Biomed Eng 4:93–107
   PubMed Web of Science ®Google Scholar
• Edwards DA, Hanes J, Caponetti G, et al. (1997). Large porous particles for pulmonary drug delivery. Science 276:1868–1871
   PubMed Web of Science ®Google Scholar
• El-Sayed IH, Huang X, El-Sayed MA. (2005). Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: Applications in oral cancer. Nano Lett 5:829–834
   PubMed Web of Science ®Google Scholar
• Ema M, Tanaka J, Kobayashi N, et al. (2012). Genotoxicity evaluation of fullerene C60 nanoparticles in a comet assay using lung cells of intratracheally instilled rats. Regul Toxicol Pharmacol 62:419–424
   PubMed Web of Science ®Google Scholar
• Fakhar-e-Alam M, Ali SM, Ibupoto ZH, et al. (2012). Sensitivity of A-549 human lung cancer cells to nanoporous zinc oxide conjugated with Photofrin. Lasers Med Sci 27:607–614
   PubMed Web of Science ®Google Scholar
• Farboud ES, Nasrollahi SA, Tabbakhi Z. (2011). Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: In vitro and in vivo studies. Int J Nanomedicine 6:611–617
   PubMed Web of Science ®Google Scholar
• Fifis T, Gamvrellis A, Crimeen-Irwin B, et al. (2004). Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J Immunol 173:3148–3154
   PubMed Web of Science ®Google Scholar
• Filipe P, Silva JN, Silva R, et al. (2009). Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol 22:266–275
   PubMed Web of Science ®Google Scholar
• Foldvari M, Bagonluri M. (2008). Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine 4:183–200
   PubMed Web of Science ®Google Scholar
• Fraga S, Faria H, Soares ME, et al. (2013). Influence of the surface coating on the cytotoxicity, genotoxicity and uptake of gold nanoparticles in human HepG2 cells. J Appl Toxicol 33:1111–1119
   PubMed Web of Science ®Google Scholar
• Fujita K, Morimoto Y, Endoh S, et al. (2010). Identification of potential biomarkers from gene expression profiles in rat lungs intratracheally instilled with C60 fullerenes. Toxicology 274:34–41
   PubMed Web of Science ®Google Scholar
• Genter MB, Newman NC, Shertzer HG, et al. (2012). Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicol Pathol 40:1004–1013
   PubMed Web of Science ®Google Scholar
• George S, Pokhrel S, Xia T, et al. (2010). Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano 4:15–29
   PubMed Web of Science ®Google Scholar
• Gosens I, Post JA, de la Fonteyne LJ, et al. (2010). Impact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammation. Part Fibre Toxicol 7:37--47
   PubMed Web of Science ®Google Scholar
• Grassian VH, O'Shaughnessy PT, Adamcakova-Dodd A, et al. (2007). Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm. Environ Health Perspect 115:397–402
   PubMed Web of Science ®Google Scholar
• Guidi P, Nigro M, Bernardeschi M, et al. (2013). Genotoxicity of amorphous silica particles with different structure and dimension in human and murine cell lines. Mutagenesis 28:171–180
   PubMed Web of Science ®Google Scholar
• Han G, Ghosh P, Rotello VM. (2007). Functionalized gold nanoparticles for drug delivery. Nanomedicine (Lond) 2:113–123
   PubMed Web of Science ®Google Scholar
• Hardy CL, Lemasurier JS, Belz GT, et al. (2012). Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. J Immunol 188:1431–1441
   PubMed Web of Science ®Google Scholar
• Hardy CL, Lemasurier JS, Mohamud R, et al. (2013). Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints. J Immunol 191:5278–5290
   PubMed Web of Science ®Google Scholar
• Heng BC, Zhao X, Xiong S, et al. (2010). Toxicity of zinc oxide (ZnO) nanoparticles on human bronchial epithelial cells (BEAS-2B) is accentuated by oxidative stress. Food Chem Toxicol 48:1762–1766
   PubMed Web of Science ®Google Scholar
• Hirn S, Semmler-Behnke M, Schleh C, et al. (2011). Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 77:407–416
   PubMed Web of Science ®Google Scholar
• Hoet PH, Bruske-Hohlfeld I, Salata OV. (2004). Nanoparticles – known and unknown health risks. J Nanobiotechnology 2:12--26
   PubMedGoogle Scholar
• Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. (2008). Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 8:142–152
   PubMed Web of Science ®Google Scholar
• Huang X, Jain PK, El-Sayed IH, El-Sayed MA. (2007). Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2:681–693
   PubMed Web of Science ®Google Scholar
• Huang X, Peng X, Wang Y, et al. (2010). A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4:5887–5896
   PubMed Web of Science ®Google Scholar
• Hussain A, Arnold JJ, Khan MA, Ahsan F. (2004). Absorption enhancers in pulmonary protein delivery. J Control Release 94:15–24
   PubMed Web of Science ®Google Scholar
• Hussain S, Vanoirbeek JA, Luyts K, et al. (2011). Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J 37:299–309
   PubMed Web of Science ®Google Scholar
• Hussain SM, Hess KL, Gearhart JM, et al. (2005). In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975–983
   PubMed Web of Science ®Google Scholar
• Inoue K, Yanagisawa R, Koike E, et al. (2010). Repeated pulmonary exposure to single-walled carbon nanotubes exacerbates allergic inflammation of the airway: Possible role of oxidative stress. Free Radic Biol Med 48:924–934
   PubMed Web of Science ®Google Scholar
• Janeway CA Jr, Bottomly K. (1994). Signals and signs for lymphocyte responses. Cell 76:275–285
   PubMed Web of Science ®Google Scholar
• Janeway CA, Jr, Medzhitov R. (2002). Innate immune recognition. Annu Rev Immunol 20:197–216
   PubMed Web of Science ®Google Scholar
• Jang S, Park JW, Cha HR, et al. (2012). Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation. Int J Nanomedicine 7:1329–1343
   PubMed Web of Science ®Google Scholar
• Jensen DK, Jensen LB, Koocheki S, et al. (2012). Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. J Control Release 157:141–148
   PubMed Web of Science ®Google Scholar
• John AE, Lukacs NW, Berlin AA, et al. (2003). Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease. FASEB J 17:2296–2298
   PubMed Web of Science ®Google Scholar
• Johnston HJ, Hutchison G, Christensen FM, et al. (2010). A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40:328–346
   PubMed Web of Science ®Google Scholar
• Kalishwaralal K, Banumathi E, Ram Kumar Pandian S, et al. (2009). Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf B Biointerfaces 73:51–57
   PubMed Web of Science ®Google Scholar
• Kao YY, Chen YC, Cheng TJ, et al. (2012). Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity. Toxicol Sci 125:462–472
   PubMed Web of Science ®Google Scholar
• Karlson TD, Kong YY, Hardy CL, et al. (2013). The signalling imprints of nanoparticle uptake by bone marrow derived dendritic cells. Methods 60:275–283
   PubMed Web of Science ®Google Scholar
• Karlsson HL, Cronholm P, Gustafsson J, Moller L. (2008). Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 21:1726–1732
   PubMed Web of Science ®Google Scholar
• Kaur G, Narang RK, Rath G, Goyal AK. (2012). Advances in pulmonary delivery of nanoparticles. Artif Cells Blood Substit Immobil Biotechnol 40:75–96
   PubMed Web of Science ®Google Scholar
• Keijzer C, Spiering R, Silva AL, et al. (2013). PLGA nanoparticles enhance the expression of retinaldehyde dehydrogenase enzymes in dendritic cells and induce FoxP3 T-cells in vitro. J Control Release 168:35–40
   PubMed Web of Science ®Google Scholar
• Kim YH, Fazlollahi F, Kennedy IM, et al. (2010). Alveolar epithelial cell injury due to zinc oxide nanoparticle exposure. Am J Respir Crit Care Med 182:1398–1409
   PubMed Web of Science ®Google Scholar
• Klippstein R, Pozo D. (2010). Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomedicine 6:523–529
   PubMed Web of Science ®Google Scholar
• Konduru NV, Tyurina YY, Feng W, et al. (2009). Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. PLoS One 4:e4398
   PubMed Web of Science ®Google Scholar
• Kumar M, Behera AK, Lockey RF, et al. (2002). Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum Gene Ther 13:1415–1425
   PubMed Web of Science ®Google Scholar
• Kumar M, Kong X, Behera AK, et al. (2003). Chitosan IFN-gamma-pDNA nanoparticle (CIN) therapy for allergic asthma. Genet Vaccines Ther 1:3--12
   PubMedGoogle Scholar
• Kunzmann A, Andersson B, Vogt C, et al. (2011). Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol 253:81–93
   PubMed Web of Science ®Google Scholar
• Lai SK, Suk JS, Pace A, et al. (2011). Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials 32:6285–6290
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Hammad H. (2009). Biology of lung dendritic cells at the origin of asthma. Immunity 31:412–424
   PubMed Web of Science ®Google Scholar
• Larsen ST, Roursgaard M, Jensen KA, Nielsen GD. (2010). Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice. Basic Clin Pharmacol Toxicol 106:114–117
   PubMed Web of Science ®Google Scholar
• Latimer P, Menchaca M, Snyder RM, et al. (2009). Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Exp Biol Med (Maywood) 234:1244–1252
   PubMed Web of Science ®Google Scholar
• Lee DW, Shirley SA, Lockey RF, Mohapatra SS. (2006). Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res 7:112
   PubMed Web of Science ®Google Scholar
• Li B, Ze Y, Sun Q, et al. (2013). Molecular mechanisms of nanosized titanium dioxide-induced pulmonary injury in mice. PLoS One 8:e55563
   PubMed Web of Science ®Google Scholar
• Madani SY, Shabani F, Dwek MV, Seifalian AM. (2013). Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment. Int J Nanomedicine 8:941–950
   PubMed Web of Science ®Google Scholar
• Madl AK, Pinkerton KE. (2009). Health effects of inhaled engineered and incidental nanoparticles. Crit Rev Toxicol 39:629–658
   PubMed Web of Science ®Google Scholar
• Maiseyeu A, Badgeley MA, Kampfrath T, et al. (2012). In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles. Arterioscler Thromb Vasc Biol 32:962–970
   PubMed Web of Science ®Google Scholar
• Mano SS, Kanehira K, Sonezaki S, Taniguchi A. (2012). Effect of polyethylene glycol modification of TiO2 nanoparticles on cytotoxicity and gene expressions in human cell lines. Int J Mol Sci 13:3703–3717
   PubMed Web of Science ®Google Scholar
• Marches R, Mikoryak C, Wang RH, et al. (2011). The importance of cellular internalization of antibody-targeted carbon nanotubes in the photothermal ablation of breast cancer cells. Nanotechnology 22:095101 (1--10)
   Google Scholar
• Martinez Gomez JM, Fischer S, Csaba N, et al. (2007). A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles. Pharm Res 24:1927–1935
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Ishihara T, Ishizaki J, et al. (2009). Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model. Cell Immunol 260:33–38
   PubMed Web of Science ®Google Scholar
• McCarthy J, Inkielewicz-Stepniak I, Corbalan JJ, Radomski MW. (2012). Mechanisms of toxicity of amorphous silica nanoparticles on human lung submucosal cells in vitro: Protective effects of fisetin. Chem Res Toxicol 25:2227–2235
   PubMed Web of Science ®Google Scholar
• Minigo G, Scholzen A, Tang CK, et al. (2007). Poly-L-lysine-coated nanoparticles: A potent delivery system to enhance DNA vaccine efficacy. Vaccine 25:1316–1327
   PubMed Web of Science ®Google Scholar
• Mitchell LA, Gao J, Wal RV, et al. (2007). Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci 100:203–214
   PubMed Web of Science ®Google Scholar
• Monforte V, Ussetti P, Lopez R, et al. (2009). Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: Pharmacokinetics and safety. J Heart Lung Transplant 28:170–175
   PubMed Web of Science ®Google Scholar
• Mossman BT, Churg A. (1998). Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 157:1666–1680
   PubMed Web of Science ®Google Scholar
• Mottram PL, Leong D, Crimeen-Irwin B, et al. (2007). Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: Formulation of a model vaccine for respiratory syncytial virus. Mol Pharm 4:73–84
   PubMed Web of Science ®Google Scholar
• Muhlfeld C, Rothen-Rutishauser B, Blank F, et al. (2008). Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol Lung Cell Mol Physiol 294:L817–L829
   PubMed Web of Science ®Google Scholar
• Nafee N, Taetz S, Schneider M, et al. (2007). Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: Effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine 3:173–183
   PubMed Web of Science ®Google Scholar
• Napierska D, Rabolli V, Thomassen LC, et al. (2012a). Oxidative stress induced by pure and iron-doped amorphous silica nanoparticles in subtoxic conditions. Chem Res Toxicol 25:828–837
   PubMed Web of Science ®Google Scholar
• Napierska D, Thomassen LC, Lison D, et al. (2010). The nanosilica hazard: Another variable entity. Part Fibre Toxicol 7:39--70
   PubMed Web of Science ®Google Scholar
• Napierska D, Thomassen LC, Vanaudenaerde B, et al. (2012b). Cytokine production by co-cultures exposed to monodisperse amorphous silica nanoparticles: The role of size and surface area. Toxicol Lett 211:98–104
   PubMed Web of Science ®Google Scholar
• Nassimi M, Schleh C, Lauenstein HD, et al. (2010). A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm 75:107–116
   PubMed Web of Science ®Google Scholar
• Nemmar A, Hoet PH, Vandervoort P, et al. (2007). Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: Role of P-selectin. J Thromb Haemost 5:1217–1226
   PubMed Web of Science ®Google Scholar
• Nemmar A, Hoylaerts MF, Hoet PH, et al. (2003). Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 186:38–45
   PubMed Web of Science ®Google Scholar
• Nicod LP. (1999). Pulmonary defence mechanisms. Respiration 66:2–11
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Oberdorster E, Oberdorster J. (2005). Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839
   PubMed Web of Science ®Google Scholar
• Ogami A, Yamamoto K, Morimoto Y, et al. (2011). Pathological features of rat lung following inhalation and intratracheal instillation of C60 fullerene. Inhal Toxicol 23:407–416
   PubMed Web of Science ®Google Scholar
• Oikonomou N, Harokopos V, Zalevsky J, et al. (2006). Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS One 1:e108
   PubMed Web of Science ®Google Scholar
• Oves M, Khan MS, Zaidi A, et al. (2013). Antibacterial and cytotoxic efficacy of extracellular silver nanoparticles biofabricated from chromium reducing novel OS4 strain of Stenotrophomonas maltophilia. PLoS One 8:e59140
   PubMed Web of Science ®Google Scholar
• Pan Z, Lee W, Slutsky L, et al. (2009). Adverse effects of titanium dioxide nanoparticles on human dermal fibroblasts and how to protect cells. Small 5:511–520
   PubMed Web of Science ®Google Scholar
• Park EJ, Bae E, Yi J, et al. (2010a). Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 30:162–168
   PubMed Web of Science ®Google Scholar
• Park EJ, Cho WS, Jeong J, et al. (2009). Pro-inflammatory and potential allergic responses resulting from B cell activation in mice treated with multi-walled carbon nanotubes by intratracheal instillation. Toxicology 259:113–121
   PubMed Web of Science ®Google Scholar
• Park EJ, Choi K, Park K. (2011). Induction of inflammatory responses and gene expression by intratracheal instillation of silver nanoparticles in mice. Arch Pharm Res 34:299–307
   PubMed Web of Science ®Google Scholar
• Park EJ, Kim H, Kim Y, et al. (2010b). Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice. Toxicology 275:65–71
   PubMed Web of Science ®Google Scholar
• Park HS, Kim KH, Jang S, et al. (2010c). Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles. Int J Nanomedicine 5:505–515
   PubMed Web of Science ®Google Scholar
• Pastorino F, Di Paolo D, Piccardi F, et al. (2008). Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin. Clin Cancer Res 14:7320–7329
   PubMed Web of Science ®Google Scholar
• Patton JS, Byron PR. (2007). Inhaling medicines: Delivering drugs to the body through the lungs. Nat Rev Drug Discov 6:67–74
   PubMed Web of Science ®Google Scholar
• Pilcer G, Amighi K. (2010). Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm 392:1–19
   PubMed Web of Science ®Google Scholar
• Pirooznia N, Hasannia S, Lotfi AS, Ghanei M. (2012). Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: In vitro characterization as an effective aerosol formulation in pulmonary diseases. J Nanobiotechnol 10:20--34
   PubMed Web of Science ®Google Scholar
• Prato M, Kostarelos K, Bianco A. (2008). Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res 41:60–68
   PubMed Web of Science ®Google Scholar
• Randall TD. (2010). Pulmonary dendritic cells: Thinking globally, acting locally. J Exp Med 207:451–454
   PubMed Web of Science ®Google Scholar
• Reddy ST, van der Vlies AJ, Simeoni E, et al. (2007). Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25:1159–1164
   PubMed Web of Science ®Google Scholar
• Regner M, Culley F, Fontannaz P, et al. (2004). Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infection. Microbes Infect 6:666–675
   PubMed Web of Science ®Google Scholar
• Rossi EM, Pylkkanen L, Koivisto AJ, et al. (2010). Inhalation exposure to nanosized and fine TiO2 particles inhibits features of allergic asthma in a murine model. Part Fibre Toxicol 7:35--48
   PubMed Web of Science ®Google Scholar
• Roursgaard M, Poulsen SS, Kepley CL, et al. (2008). Polyhydroxylated C60 fullerene (fullerenol) attenuates neutrophilic lung inflammation in mice. Basic Clin Pharmacol Toxicol 103:386–388
   PubMed Web of Science ®Google Scholar
• Roursgaard M, Poulsen SS, Poulsen LK, et al. (2010). Time-response relationship of nano and micro particle induced lung inflammation. Quartz as reference compound. Hum Exp Toxicol 29:915–933
   PubMed Web of Science ®Google Scholar
• Ruenraroengsak P, Novak P, Berhanu D, et al. (2012). Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles. Nanotoxicology 6:94–108
   PubMed Web of Science ®Google Scholar
• Ryan JJ, Bateman HR, Stover A, et al. (2007). Fullerene nanomaterials inhibit the allergic response. J Immunol 179:665–672
   PubMed Web of Science ®Google Scholar
• Safari D, Marradi M, Chiodo F, et al. (2012). Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine. Nanomedicine (Lond) 7:651–662
   PubMed Web of Science ®Google Scholar
• San Gil F, Turner B, Walker MJ, et al. (1999). Contribution of adjuvant to adaptive immune responses in mice against Actinobacillus pleuropneumoniae. Microbiology 145 (Pt 9):2595–2603
   PubMedGoogle Scholar
• Sandberg WJ, Lag M, Holme JA, et al. (2012). Comparison of non-crystalline silica nanoparticles in IL-1beta release from macrophages. Part Fibre Toxicol 9:32--44
   PubMed Web of Science ®Google Scholar
• Satoh M, Takayanagi I. (2006). Pharmacological studies on fullerene (C60), a novel carbon allotrope, and its derivatives. J Pharmacol Sci 100:513–518
   PubMed Web of Science ®Google Scholar
• Sayes CM, Liang F, Hudson JL, et al. (2006a). Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 161:135–142
   PubMed Web of Science ®Google Scholar
• Sayes CM, Marchione AA, Reed KL, Warheit DB. (2007). Comparative pulmonary toxicity assessments of C60 water suspensions in rats: Few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett 7:2399–2406
   PubMed Web of Science ®Google Scholar
• Sayes CM, Wahi R, Kurian PA, et al. (2006b). Correlating nanoscale titania structure with toxicity: A cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci 92:174–185
   PubMed Web of Science ®Google Scholar
• Scholl I, Kopp T, Bohle B, Jensen-Jarolim E. (2006). Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy. Immunol Allergy Clin North Am 26:349–364, ix
   PubMed Web of Science ®Google Scholar
• Schulz M, Ma-Hock L, Brill S, et al. (2012). Investigation on the genotoxicity of different sizes of gold nanoparticles administered to the lungs of rats. Mutat Res 745:51–57
   PubMed Web of Science ®Google Scholar
• Semmler-Behnke M, Kreyling WG, Lipka J, et al. (2008). Biodistribution of 1.4- and 18-nm gold particles in rats. Small 4:2108–2111
   PubMed Web of Science ®Google Scholar
• Shen S, Liu Y, Huang P, Wang J. (2009). In vitro cellular uptake and effects of Fe3O4 magnetic nanoparticles on HeLa cells. J Nanosci Nanotechnol 9:2866–2871
   PubMed Web of Science ®Google Scholar
• Shi H, Magaye R, Castranova V, Zhao J. (2013). Titanium dioxide nanoparticles: A review of current toxicological data. Part Fibre Toxicol 10:15--47
   PubMed Web of Science ®Google Scholar
• Shoenfelt J, Mitkus RJ, Zeisler R, et al. (2009). Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter. J Leukoc Biol 86:303–312
   PubMed Web of Science ®Google Scholar
• Shvedova AA, Kisin ER, Mercer R, et al. (2005). Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289:L698–L708
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Makino K. (2008). Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surf B Biointerfaces 66:274--280
   Google Scholar
• Song KS, Sung JH, Ji JH, et al. (2012). Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats. Nanotoxicology 7:169–180
   PubMed Web of Science ®Google Scholar
• Sperling RA, Rivera Gil P, Zhang F, et al. (2008). Biological applications of gold nanoparticles. Chem Soc Rev 37:1896–1908
   PubMed Web of Science ®Google Scholar
• Stebounova LV, Adamcakova-Dodd A, Kim JS, et al. (2011). Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol 8:5--16
   PubMed Web of Science ®Google Scholar
• Steinmuller C, Franke-Ullmann G, Lohmann-Matthes ML, Emmendorffer A. (2000). Local activation of nonspecific defense against a respiratory model infection by application of interferon-gamma: Comparison between rat alveolar and interstitial lung macrophages. Am J Respir Cell Mol Biol 22:481–490
   PubMed Web of Science ®Google Scholar
• Suh WH, Suslick KS, Stucky GD, Suh YH. (2009). Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol 87:133–170
   PubMed Web of Science ®Google Scholar
• Sung JC, Pulliam BL, Edwards DA. (2007). Nanoparticles for drug delivery to the lungs. Trends Biotechnol 25:563–570
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Park JD, et al. (2011). Subchronic inhalation toxicity of gold nanoparticles. Part Fibre Toxicol 8:16--33
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Yoon JU, et al. (2008). Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol 20:567–574
   PubMed Web of Science ®Google Scholar
• Szacilowski K, Macyk W, Drzewiecka-Matuszek A, et al. (2005). Bioinorganic photochemistry: Frontiers and mechanisms. Chem Rev 105:2647–2694
   PubMed Web of Science ®Google Scholar
• Szalay B, Tatrai E, Nyiro G, et al. (2012). Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments. J Appl Toxicol 32:446–453
   PubMed Web of Science ®Google Scholar
• Ungaro F, d'Angelo I, Miro A, et al. (2012). Engineered PLGA nano- and micro-carriers for pulmonary delivery: Challenges and promises. J Pharm Pharmacol 64:1217–1235
   PubMed Web of Science ®Google Scholar
• Vardharajula S, Ali SZ, Tiwari PM, et al. (2012). Functionalized carbon nanotubes: Biomedical applications. Int J Nanomedicine 7:5361–5374
   PubMed Web of Science ®Google Scholar
• Verma NK, Crosbie-Staunton K, Satti A, et al. (2013). Magnetic core-shell nanoparticles for drug delivery by nebulization. J Nanobiotechnol 11:1--12
   PubMed Web of Science ®Google Scholar
• Vigneshwaran N, Kathe AA, Varadarajan PV, et al. (2007). Functional finishing of cotton fabrics using silver nanoparticles. J Nanosci Nanotechnol 7:1893–1897
   PubMed Web of Science ®Google Scholar
• Vranic S, Garcia-Verdugo I, Darnis C, et al. (2013). Internalization of SiO2 nanoparticles by alveolar macrophages and lung epithelial cells and its modulation by the lung surfactant substitute Curosurerreg®. Environ Sci Pollut Res Int 20:2761–2770
   PubMed Web of Science ®Google Scholar
• Wang H, Zou C, Tian C, et al. (2011). A novel gas ionization sensor using Pd nanoparticle-capped ZnO. Nanoscale Res Lett 6:534--541
   PubMedGoogle Scholar
• Wang JJ, Sanderson BJ, Wang H. (2007). Cytotoxicity and genotoxicity of ultrafine crystalline SiO2 particulate in cultured human lymphoblastoid cells. Environ Mol Mutagen 48:151–157
   PubMed Web of Science ®Google Scholar
• Wang W, Zhu R, Xie Q, et al. (2012). Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomed 7:3667–3677
   PubMed Web of Science ®Google Scholar
• Wang X, Xu W, Kong X, et al. (2009). Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. Respir Res 10:66--73
   PubMedGoogle Scholar
• Wang X, Xu W, Mohapatra S, et al. (2008). Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genet Vaccines Ther 6:7--15
   PubMedGoogle Scholar
• Wang X, Zang JJ, Wang H, et al. (2010). Pulmonary toxicity in mice exposed to low and medium doses of water-soluble multi-walled carbon nanotubes. J Nanosci Nanotechnol 10:8516–8526
   PubMed Web of Science ®Google Scholar
• Warheit DB, Webb TR, Colvin VL, et al. (2007a). Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: Toxicity is not dependent upon particle size but on surface characteristics. Toxicol Sci 95:270–280
   PubMed Web of Science ®Google Scholar
• Warheit DB, Webb TR, Reed KL, et al. (2007b). Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: Differential responses related to surface properties. Toxicology 230:90–104
   PubMed Web of Science ®Google Scholar
• Wiesenthal A, Hunter L, Wang S, et al. (2011). Nanoparticles: Small and mighty. Int J Dermatol 50:247–254
   PubMed Web of Science ®Google Scholar
• Wissinger E, Goulding J, Hussell T. (2009). Immune homeostasis in the respiratory tract and its impact on heterologous infection. Semin Immunol 21:147–155
   PubMed Web of Science ®Google Scholar
• Wong KK, Ng A, Chen XY, et al. (2012). Effect of ZnO nanoparticle properties on dye-sensitized solar cell performance. ACS Appl Mater Interfaces 4:1254–1261
   PubMed Web of Science ®Google Scholar
• Xia T, Kovochich M, Brant J, et al. (2006). Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794–1807
   PubMed Web of Science ®Google Scholar
• Xiang SD, Scalzo-Inguanti K, Minigo G, et al. (2008). Promising particle-based vaccines in cancer therapy. Expert Rev Vaccines 7:1103–1119
   PubMed Web of Science ®Google Scholar
• Xiang SD, Scholzen A, Minigo G, et al. (2006). Pathogen recognition and development of particulate vaccines: Does size matter? Methods 40:1–9
   PubMed Web of Science ®Google Scholar
• Xie J, Liu G, Eden HS, et al. (2011). Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 44:883–892
   PubMed Web of Science ®Google Scholar
• Yang M, Yamamoto H, Kurashima H, et al. (2012). Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles. Eur J Pharm Sci 47:235–243
   PubMed Web of Science ®Google Scholar
• Yang S, Damiano MG, Zhang H, et al. (2013). Biomimetic, synthetic HDL nanostructures for lymphoma. Proc Natl Acad Sci U S A 110:2511–2516
   PubMed Web of Science ®Google Scholar
• Yazdi AS, Guarda G, Riteau N, et al. (2010). Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad Sci U S A 107:19449–19454
   PubMed Web of Science ®Google Scholar
• Yuan Y, Ding J, Xu J, et al. (2010). TiO2 nanoparticles co-doped with silver and nitrogen for antibacterial application. J Nanosci Nanotechnol 10:4868–4874
   PubMed Web of Science ®Google Scholar
• Zagorovsky K, Chan WC. (2013). A plasmonic DNAzyme strategy for point-of-care genetic detection of infectious pathogens. Angew Chem Int Ed Engl 52:3168–3171
   PubMed Web of Science ®Google Scholar
• Zakharian TY, Seryshev A, Sitharaman B, et al. (2005). A fullerene-paclitaxel chemotherapeutic: Synthesis, characterization, and study of biological activity in tissue culture. J Am Chem Soc 127:12508–12509
   PubMed Web of Science ®Google Scholar
• Zaru M, Sinico C, De Logu A, et al. (2009). Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: In vitro and in vivo evaluation. J Liposome Res 19:68–76
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang C, Chen B, Wang X. (2012). Daunorubicin-TiO2 nanocomposites as a “smart” pH-responsive drug delivery system. Int J Nanomed 7:235–242
   PubMed Web of Science ®Google Scholar